299 related articles for article (PubMed ID: 25634217)
1. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.
Samarajeewa NU; Yang F; Docanto MM; Sakurai M; McNamara KM; Sasano H; Fox SB; Simpson ER; Brown KA
Breast Cancer Res; 2013 Apr; 15(2):R30. PubMed ID: 23566437
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: suppression of cAMP as a possible mechanism.
Docanto MM; Yang F; Callaghan B; Au CC; Ragavan R; Wang X; Furness JB; Andrews ZB; Brown KA
Breast Cancer Res Treat; 2014 Aug; 147(1):193-201. PubMed ID: 25056185
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
5. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.
Zahid H; Subbaramaiah K; Iyengar NM; Zhou XK; Chen IC; Bhardwaj P; Gucalp A; Morrow M; Hudis CA; Dannenberg AJ; Brown KA
Int J Obes (Lond); 2018 Apr; 42(4):711-720. PubMed ID: 29104286
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.
Brown KA; McInnes KJ; Hunger NI; Oakhill JS; Steinberg GR; Simpson ER
Cancer Res; 2009 Jul; 69(13):5392-9. PubMed ID: 19509226
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E
Subbaramaiah K; Iyengar NM; Morrow M; Elemento O; Zhou XK; Dannenberg AJ
J Biol Chem; 2019 Jan; 294(1):361-371. PubMed ID: 30409902
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
[TBL] [Abstract][Full Text] [Related]
10. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
11. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
12. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.
Zhao Y; Agarwal VR; Mendelson CR; Simpson ER
Endocrinology; 1996 Dec; 137(12):5739-42. PubMed ID: 8940410
[TBL] [Abstract][Full Text] [Related]
13. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
14. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
15. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
19. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
20. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]